IL37 and allergic asthma: IL-37 has been demonstrated to downregulate the proinflammatory activity of various innate immune cells [294], and it also inhibits allergic inflammation, as has been demonstrated by the local application of recombinant human IL-37 to mice suffering from experimental allergic asthma [295,299,300].